| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer | President &CEO
3 companies
Higgins John L serves as a Director at OABI and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 9 buys and 48 sells. Those positions are worth an estimated $27.7M at current prices.
Historically, Higgins John L's trades have earned a middling insider score of 66/100 across 18 rated trades. Over a 12-month horizon, 60.0% of those trades were profitable, with an average 12-month return of +8.8%.
The biggest single holding is LGND (~$27.7M) as Director. The recent filings there lean toward selling, a net 341,329 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 31, 2019 | LGND Ligand Pharmaceuticals Inc | Chief Executive Officer | Buy | 1,000 | $108.20 | $108,202.00 | +0.7% | |
| May 14, 2019 | LGND Ligand Pharmaceuticals Inc | Chief Executive Officer | Buy | 2,500 | $113.50 | $283,750.00 | +1.8% | |
| Mar 13, 2019 | LGND Ligand Pharmaceuticals Inc | Chief Executive Officer | Buy | 2,500 | $114.29 | $285,725.00 | +1.8% | |
| Aug 30, 2018 | LGND Ligand Pharmaceuticals Inc | Chief Executive Officer | Sell | 3,500 | $258.25 | $903,875.00 | -3.9% | |
| Aug 23, 2018 | TECH Bio-Techne Corp | Director | Sale+OE | 10,000 | $187.92 | $1,879,173.00 | -76.9% | |
| Aug 17, 2018 | LGND Ligand Pharmaceuticals Inc | Chief Executive Officer | Sale+OE | 34,500 | $241.96 | $8,347,559.65 | -28.0% | |
| May 15, 2018 | LGND Ligand Pharmaceuticals Inc | Chief Executive Officer | Sale+OE | 12,405 | $179.97 | $2,232,490.64 | -10.4% | |
| Feb 15, 2018 | LGND Ligand Pharmaceuticals Inc | Chief Executive Officer | Sell | 9,000 | $157.03 | $1,413,279.00 | -8.1% | |
| Jan 24, 2018 | LGND Ligand Pharmaceuticals Inc | Chief Executive Officer | Sell | 22,500 | $165.00 | $3,712,500.00 | -16.8% | |
| Jan 19, 2018 | LGND Ligand Pharmaceuticals Inc | Chief Executive Officer | Sale+OE | 28,099 | $153.70 | $4,318,901.51 | -17.3% |